Profil
Sara Blum Sherman is currently working as Vice President-Investor Relations at Exscientia AI Ltd. and Exscientia Plc.
She previously worked as Senior Director-Investor Relations & Strategy at DBV Technologies SA from 2016 to 2020 and as Head-Investor Relations at UroGen Pharma Ltd.
Aktiva positioner av Sara Blum Sherman
| Företag | Position | Start |
|---|---|---|
| EXSCIENTIA PLC | Investor Relations Kontakt | 2021-08-01 |
Exscientia AI Ltd.
Exscientia AI Ltd. Pharmaceuticals: GenericHealth Technology Provides AI and machine learning techniques based drug discovery services | Investor Relations Kontakt | - |
Tidigare kända positioner av Sara Blum Sherman
| Företag | Position | Slut |
|---|---|---|
| UROGEN PHARMA LTD. | Investor Relations Kontakt | 2021-08-01 |
| DBV TECHNOLOGIES | Offentlig kommunikationskontakt | 2020-09-01 |
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 4 |
|---|---|
DBV Technologies SA
DBV Technologies SA Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biopharmaceutical company that focuses on changing the field of immunotherapy | Health Technology |
UroGen Pharma Ltd.
UroGen Pharma Ltd. BiotechnologyHealth Technology Develops therapies for urological pathologies | Health Technology |
Exscientia AI Ltd.
Exscientia AI Ltd. Pharmaceuticals: GenericHealth Technology Provides AI and machine learning techniques based drug discovery services | Health Technology |
Exscientia Plc
Exscientia Plc Packaged SoftwareTechnology Services Function as an investment holding company whose subsidiaries provides artificial intelligence and machine learning services | Technology Services |
















